#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • JNJ-79635322 versus Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma After at Least 3 Prior Treatments

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece Italy The Netherlands Norway +1

  • A Phase 2 Study of JNJ-79635322 in Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Poland

  • Study of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece The Netherlands Spain

  • Study of mezigdomide and elranatamab combination treatment for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    Germany Greece Norway Spain

  • Comparing CT-P44 and Darzalex Faspro with lenalidomide and dexamethasone in patients with refractory or relapsed multiple myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland Spain

  • Study of Linvoseltamab in Adults with Relapsed or Refractory Multiple Myeloma

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium Spain

  • Study of Selinexor, Dexamethasone, and Bortezomib for Patients with Refractory Multiple Myeloma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Greece

  • Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Croatia Czechia Denmark Finland France +10

  • Study Comparing Mezigdomide, Bortezomib, and Dexamethasone with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia Finland France Germany +7

  • Study of isatuximab, pomalidomide and dexamethasone combination for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece Italy Norway Portugal